Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Elbirt

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
The Israel Medical Association Journal : IMAJ|July 24, 2007
The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE studyZev M Sthoeger, Abraham Eliraz, Ilan Asher, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 25, 2009
Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-respondersEli Magen, Daniel Elbirt, Nancy Agmon-Levin, et al.
The Israel Medical Association Journal : IMAJ|May 5, 2017
Idiopathic CD4 Lymphopenia: Severe CD4 Lymphopenia in the Absence of Human Immunodeficiency Virus InfectionIlan Asher, Keren Mahlab-Guri, Daniel Elbirt, et al.
The Israel Medical Association Journal : IMAJ|July 20, 2016
Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus InfectionDaniel Elbirt, Keren Mahlab-Guri, Shira Bezalel-Rosenberg, et al.
The Israel Medical Association Journal : IMAJ|May 20, 2014
Type I interferon signature in systemic lupus erythematosusShira Bezalel, Keren Mahlab Guri, Daniel Elbirt, et al.
Medicine|May 5, 2017
Hospitalizations of HIV patients in a major Israeli HIV/AIDS center during the years 2000 to 2012Keren Mahlab-Guri, Ilan Asher, Shira Bezalel-Rosenberg, et al.
The Israel Medical Association Journal : IMAJ|March 6, 2015
HIV-associated neurocognitive disorders (HAND)Daniel Elbirt, Keren Mahlab-Guri, Shira Bezalel-Rosenberg, et al.
The Israel Medical Association Journal : IMAJ|October 2, 2014
BLyS levels in sera of patients with systemic lupus erythematosus: clinical and serological correlationDaniel Elbirt, Ilan Asher, Keren Mahlab-Guri, et al.
BMC Infectious Diseases|February 19, 2024
The effect of a treatment switch to integrase Strand transfer inhibitor-based regimens on weight gain and other metabolic syndrome-related conditionsOmer Maman, Wiessam Abu Ahmad, Ofer Perzon, et al.
Journal of Autoimmunity|August 25, 2009
High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding proteinDaniela Novick, Daniel Elbirt, Galit Miller, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Israel Medical Association Journal : IMAJ|July 24, 2007
The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE studyZev M Sthoeger, Abraham Eliraz, Ilan Asher, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 25, 2009
Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-respondersEli Magen, Daniel Elbirt, Nancy Agmon-Levin, et al.
The Israel Medical Association Journal : IMAJ|May 5, 2017
Idiopathic CD4 Lymphopenia: Severe CD4 Lymphopenia in the Absence of Human Immunodeficiency Virus InfectionIlan Asher, Keren Mahlab-Guri, Daniel Elbirt, et al.
The Israel Medical Association Journal : IMAJ|July 20, 2016
Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus InfectionDaniel Elbirt, Keren Mahlab-Guri, Shira Bezalel-Rosenberg, et al.
The Israel Medical Association Journal : IMAJ|May 20, 2014
Type I interferon signature in systemic lupus erythematosusShira Bezalel, Keren Mahlab Guri, Daniel Elbirt, et al.
Medicine|May 5, 2017
Hospitalizations of HIV patients in a major Israeli HIV/AIDS center during the years 2000 to 2012Keren Mahlab-Guri, Ilan Asher, Shira Bezalel-Rosenberg, et al.
The Israel Medical Association Journal : IMAJ|March 6, 2015
HIV-associated neurocognitive disorders (HAND)Daniel Elbirt, Keren Mahlab-Guri, Shira Bezalel-Rosenberg, et al.
The Israel Medical Association Journal : IMAJ|October 2, 2014
BLyS levels in sera of patients with systemic lupus erythematosus: clinical and serological correlationDaniel Elbirt, Ilan Asher, Keren Mahlab-Guri, et al.
BMC Infectious Diseases|February 19, 2024
The effect of a treatment switch to integrase Strand transfer inhibitor-based regimens on weight gain and other metabolic syndrome-related conditionsOmer Maman, Wiessam Abu Ahmad, Ofer Perzon, et al.
Journal of Autoimmunity|August 25, 2009
High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding proteinDaniela Novick, Daniel Elbirt, Galit Miller, et al.
Pageof 8